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During the past few years, there have been two major developments, if not revolutions, in the field
of energy balance and weight regulation. The first at the molecular level, which was catalysed by
developments in DNA screening technology together with the mapping of the human genome,
has been the tremendous advances made in the identification of molecules that play a role in
the control of food intake and metabolic rate. The second, at the systemic level, which centered
upon the use of modern technologies or more robust analytical techniques for assessing human
energy expenditure in response to starvation and overfeeding, has been the publication of several
papers providing strong evidence that adaptive thermogenesis plays a much more important role
in the regulation of body weight and body composition than previously thought. Within these
same few years, several new members of the mitochondrial carrier protein family have been
identified in a variety of tissues and organs. All apparently possess uncoupling properties in
genetically-modified systems, with two of them (uncoupling protein (UCP) 2 and UCP3)
being expressed in adipose tissues and skeletal muscles, which are generally recognised as
important sites for variations in thermogenesis and/or in substrate oxidation. Considered as
breakthrough discoveries, the cloning of these genes has generated considerable optimism for
rapid advances in our molecular understanding of adaptive thermogenesis, and for the identifi-
cation of new targets for pharmacological management of obesity and cachexia. The present
paper traces first, from a historical perspective, the landmark events in the field of thermogenesis
that led to the identification of these genes encoding candidate UCP, and then addresses the con-
troversies and on-going debate about their physiological importance in adaptive thermogenesis,
in lipid oxidation or in oxidative stress. The general conclusion is that UCP2 and UCP3 may have
distinct primary functions, with UCP3 implicated in regulating the flux of lipid substrates across
the mitochondria and UCP2 in the control of mitochondrial generation of reactive oxygen
species. The distinct functions of these two UCP1 homologues have been incorporated in a con-
ceptual model to illustrate how UCP2 and UCP3 may act in concert in the overall regulation of
lipid oxidation concomitant to the prevention of lipid-induced oxidative damage.
Uncoupling proteins 2 and 3: Obesity: Starvation: Cachexia: Energy expenditure: Fat
oxidation
Life exists in a flux of energy transformations, and in the
case of an individual who is in energy balance and maintain-
ing constant body weight, the energy consumed as food is
transformed into excreta, work and heat. Quantitatively,
the values for excreta and work are small, and the typical
sedentary adult in our highly mechanized society degrades
almost all of his food energy to heat (Miller, 1982). It should
be pointed out that physical activity is often used synony-
mously with work, which has a strict definition in physics,
i.e. force distance. The efficiency of muscular work is,
however, low and most energy spent on physical activity
appears as heat. True physical work is performed on the
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external environment, whereas chemical work (including
the net cost of fat or protein synthesis, specific dynamic
action, and even BMR) will appear as heat. The existence
of man may thus be seen as a tedious degradation of poten-
tial energy in a futile effort to warm the universe, and to
quote Lavoisier & Laplace (1780): ‘life is a combustion’.
But to what extent and by what mechanisms man might
be able to adapt to changes in food availability (by turning
down the rate of heat production during undernutrition so as
to conserve energy or by turning it up during overnutrition
to burn excess energy) have been among some of the most
controversial issues in nutritional sciences during the 20th
century. These debates will certainly continue for many
more years to come, but they will be marked by several
re-evaluations of human studies of experimental starvation
and overfeeding which suggest that the control of heat pro-
duction plays a more important role in the regulation of
body weight and body composition than previously recog-
nised. These are outlined as follows:
First, in his re-analysis of data from the studies on over-
feeding human subjects published between 1967 and
1999, Stock (1999a ) has produced strong arguments for
the notion that variations in the capacity to activate heat pro-
duction in response to diet (i.e. diet-induced thermogenesis
(DIT)) contribute significantly to the ability of certain indi-
viduals to resist obesity (the so-called fast-burners) while
others become readily obese (the slow-burners). The con-
clusions of this elegant re-analysis are particularly
Fig. 1. Schematic representation of the concept of two distinct control systems under-
lying adaptive thermogenesis during prolonged starvation and subsequent refeeding.
One control system, which is a direct function of changes in the food energy supply,
responds relatively rapidly to the energy deficit. Its effector mechanisms are suppressed
early during the course of starvation, and upon refeeding they are restored relatively
rapidly as a function of energy re-availability (levels 1–4), and are activated further if
hyperphagia occurs during refeeding (level 4). Because the efferent limb of this control
system is primarily under the control of the sympathetic nervous system whose functional
state is dictated by overlapping or interacting signals arising from a variety of environ-
mental stresses including food deprivation, deficiency of essential nutrients, excess
energy intake and exposure to cold or to infections, it is referred to as the non-specific
control of thermogenesis, and is likely to occur primarily in organs and/or tissues with a
high specific metabolic rate (e.g. liver, kidneys, brown adipose tissue). The other control
system, by contrast, is independent of the functional state of the sympathetic nervous
system, has a much slower time-constant by virtue of its response only to signals arising
from the state of depletion–repletion of the fat stores; it is therefore referred to as the
control system operating through an adipose-specific control of thermogenesis.While
suppression of this adipose-specific thermogenesis during starvation and during refeed-
ing leads to energy conservation, the energy thus spared during refeeding is directed
specifically at the replenishment of the fat stores, resulting in an accelerated fat recovery,
a phenomenon that could contribute to the disproportionately rapid rate of fat relative to
lean tissue recovery during refeeding after substantial fat stores depletion. Adapted from
Dulloo & Jacquet (1998; 2001).
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reinforced by the recent overfeeding study of Levine et al.
(1999) which demonstrated the role of DIT in resistance
to fatness by the assessment of total energy expenditure
under free living conditions using the technique of doubly-
labelled water.
Second, the application of a more robust analysis to
new and older data on changes in BMR and body com-
position in response to starvation and therapeutic slim-
ming have confirmed the long-held views that the rate
of heat production falls promptly, and to an extent well
beyond that explained by the loss of body weight and
changes in body composition (Luke & Schoeller, 1992;
Leibel et al. 1995). Such suppression of thermogenesis
in response to negative energy balance has also been
demonstrated by doubly-labelled water and whole-body
respirometer measurements in the male and female vol-
unteers who have been energy-restricted for 2 years
while confined inside Biosphere 2, a self-contained eco-
logic ‘miniworld’ and prototype planetary habitat built
in Arizona (Weyer et al. 2000).
Third, using both statistical and numerical approaches, a
series of re-analyses of data from the classic Minnesota
experiment of semi-starvation and refeeding conducted by
Keys et al. (1950) have revealed that the extent to which
this phenomenon of suppressed thermogenesis occurs
during weight loss is partly determined by the degree of
depletion of the fat stores, and that it persists during sub-
sequent weight recovery, with the energy thus conserved
being directed specifically at the rapid restoration of the
fat stores (Dulloo et al. 1996; Dulloo & Jacquet, 1998).
This ‘continuum’ in the existence of this link between sup-
pressed thermogenesis and fat depletion during both phases
of weight loss and weight recovery underscores the exist-
ence of an autoregulatory feedback system in which signals
from the depleted adipose fat stores exert a suppressive
effect on thermogenesis (Dulloo & Jacquet, 2001); this adi-
pose-specific control of thermogenesis is conceptualized as
one of two distinct control systems underlying adaptive
thermogenesis (Fig. 1).
Taken together, these re-evaluations and new findings
therefore reinforce the notion that adaptive changes in ther-
mogenesis can contribute importantly to human variability in
susceptibility to obesity, to the difficulties in maintaining
weight losses on low-energy regimens, and to the ease
with which body fat is recovered after therapeutic slimming
or after malnutrition and cachexia. An understanding of the
molecular–physiological mechanisms that underlie such
changes in thermogenesis contributing to the defence of
body weight and body composition would no doubt pave
the way for the development of more effective therapies in
the management of human obesity and cachexia. In this con-
text, the cloning of several new members of the mitochon-
drial carrier protein family, which apparently possess
uncoupling (hence thermogenic) properties has provided
candidate genes that could modulate these adaptive changes
in thermogenesis (Ricquier, 1999). The present paper first
traces the physiological rationale that led to the identification
of these candidate ‘uncoupling’ proteins (UCP) and then
addresses the on-going debate about whether they have phys-
iological importance in adaptive thermogenesis, in substrate
metabolism or in oxidative stress.
The search for molecular mechanisms of thermogenesis
From a physiological standpoint, the variations in heat pro-
duction that serve the purpose of buffering body weight
against energy imbalance are embodied within the concept
of adaptive or regulatory thermogenesis, a term that devel-
oped by analogy to thermoregulatory thermogenesis which
describes the variations in heat production that serve to buf-
fer the body’s core temperature against changes in the
environmental temperature. Indeed, since the classic studies
of experimental overfeeding of the late 1960s (Miller &
Mumford, 1967; Miller et al. 1967), the search for mechan-
isms underlying DIT has been intimately linked to that for
thermoregulatory non-shivering thermogenesis in body-
temperature regulation (Trayhurn, 1990). By the late
1970s, this search culminated in the proposal by Rothwell
& Stock (1979) that these two forms of thermogenesis (in
response to diet and to cold) have a common origin in
brown adipose tissue (BAT), a tissue whose thermogenic
activity is primarily mediated by the uncoupling of mito-
chondrial respiration (Nicholls & Rial, 1999), and well
known for its importance in heat production during
exposure to cold in mammals, including human subjects
(Girardier, 1983; Lean et al. 1986; Lean, 1989; Trayhurn,
1990).
The sympathetic nervous system–brown adipose tissue–
uncoupling protein axis
A schematic diagram indicating the principle of uncoupling
in BAT is depicted in Fig. 2. According to the chemiosmotic
model of oxidative phosphorylation, the driving force to
capture useful energy via synthesis of ATP along the mito-
chondrial respiratory chain is linked to the transport of pro-
tons across the inner mitochondrial membrane. Brown
adipocytes, however, are unique in expressing a UCP
(abbreviated as UCP, but more recently referred to as
UCP1) which, under the control of noradrenaline released
from the sympathetic nervous system (SNS), allows protons
to leak back across the inner mitochondrial membrane. The
resulting dissipation of the proton electrochemical gradient
(a phenomenon referred to as ‘proton leak’) allows substrate
oxidation to occur without concomitant capture of some of
the useful energy via the synthesis of ATP. The net effect
during activation of UCP (by cold or diet) is that substrate
oxidation is effectively uncoupled from phosphorylation
with a resultant increase in heat production.
During much of the 1980s, a considerable body of evi-
dence converged in support of an important role for the
SNS–BAT–UCP axis in the control of thermogenesis in
laboratory animals (Landsberg et al. 1984; Dulloo & Miller,
1987; Himms-Hagen, 1989; Trayhurn, 1990). The results
are embodied in the schematic diagram in Fig. 3. In rats
and mice kept at laboratory temperature (21–238C), the
SNS–BAT–UCP axis is activated by overfeeding and sup-
pressed during starvation, and hence plays a contributory
role in mediating the increases and decreases in thermogen-
esis respectively. During refeeding after starvation, the
SNS–BAT–UCP axis is rapidly reactivated to levels that
vary according to the level of food intake. In addition to
such dietary energy regulation, the SNS–BAT–UCP axis
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is modulated by diet composition, and is markedly increased
in response to dietary deficiencies, such as in protein, in
essential fatty acids or in certain minerals (e.g. Fe), all of
which result in rapid and marked activation of both BAT
and whole-body thermogenesis. Also depicted in the Fig. 3
is the fact that if these earlier-mentioned experiments are
conducted in the cold (usually ,108C), the dietary regu-
lations or modulations of the SNS–BAT–UCP axis are vir-
tually abolished, thereby underscoring the over-riding effect
of the cold stimulus in activating this axis for thermoregula-
tory needs independently of diet. Conversely, if the experi-
ments are conducted in rats and mice housed within their
thermoneutral zone, i.e. when the energy expended for ther-
mal regulation is minimal, the effects of diet on the SNS–
BAT–UCP axis are also considerably blunted, although
not entirely abolished by extremes of dietary manipulation.
Indeed, even under such conditions of thermoneutrality, this
axis is also activated in response to low-protein diets and
suppressed during total starvation (fasting). The subsequent
demonstrations that several animal models of genetic obes-
ity show reduced capacity for DIT in parallel to defects in
the SNS–BAT–UCP axis (Landsberg et al. 1984;
Himms-Hagen, 1989; Trayhurn, 1990), and that bilateral
sympathetic denervation of interscapular BAT in lean
mice led to an elevated efficiency of energy utilization
(hence decreased thermogenesis) resulting in greater fat
deposition (Dulloo & Miller, 1984) have provided strong
support for a role for the SNS–BAT–UCP axis in the con-
trol of DIT and in energy balance regulation. Although in
human subjects, several lines of evidence are consistent
with an important role for SNS in the regulation of thermo-
genesis (Acheson et al. 1983; Landsberg et al. 1984; Astrup
& Macdonald, 1998), the importance of BAT as a site of
adaptive thermogenesis in the adult human subject proved
to be elusive. The discovery of a new receptor (the atypical
b3 adrenoceptor), through which noradrenaline released by
the SNS primarily activates BAT thermogenesis, offered
hope for selective targeting in the development of thermo-
genic drugs for the treatment of obesity (Arch et al.
1984). The main motivation behind such pharmacological
research and drug development was that even if the SNS–
BAT–UCP may not have physiological importance in
human weight regulation, albeit under conditions of our
modern lifestyle, the possibility that BAT–UCP could be
reactivated upon chronic sympathomimetic stimulation via
selective targeting of this tissue was (and still remains) an
appealing strategy for the management of human obesity
via pharmacological stimulation of metabolic rate (Lean
et al. 1986; Lean, 1989).
Search for skeletal muscle uncoupling protein homologues
By the early 1990s, however, enthusiasm had waned, largely
because the new drugs developed on the basis of their selec-
tivity for the b3 adrenoceptor in rodents had failed to fulfil
the criteria of a safe and effective therapy for human obesity
(Weyer et al. 1999). This situation served to fuel further
doubts about the importance and/or recruitability of
BAT–UCP in the adult human subject, and shifted greater
attention to the liver (Berry et al. 1985; Ma et al. 1987;
Iossa et al. 2000) and particularly to the skeletal muscle,
which by its sheer size (30–40 % body weight) and import-
ant contribution to daily metabolic rate (.20 % even in
‘sedentary human subjects’) has long been advocated as
the major site for adaptive thermogenesis in large mammals.
Besides, even in the small laboratory rat, the skeletal muscle
is thought to be an important site for cold-induced non-shi-
vering thermogenesis (Jansky, 1995) and to contribute sub-
stantially to energy conservation during starvation (Ma &
Foster, 1986; Ardawi et al. 1989). Furthermore, the lack
of supporting evidence for the involvement of the SNS–
BAT–UCP axis in the sustained energy conservation
directed at accelerating fat deposition during weight recov-
ery (Dulloo et al. 1995) led to us to consider the skeletal
muscle as the prime candidate site where suppression of
the adipose-specific control of thermogenesis occurs during
starvation and refeeding (Fig. 1). In contrast to heat gener-
ated by BAT, however, the mechanisms modulating skeletal
muscle thermogenesis have remained elusive.
The publications of two papers in 1996 probably
prompted the search for UCP and/or UCP homologues in
skeletal muscle and other tissues, namely: (1) the report
Fig. 2. Schematic diagram illustrating how brown adipose tissue
generates heat. When activated by cold or diet, the uncoupling pro-
tein (UCP) in brown fat cells allows protons (H+) to pass through
the inner mitochondrial membrane, thereby abolishing the proton
gradient needed to drive ATP synthesis. FFA, free fatty acid.
Adapted from Nedergaard & Cannon (1992) and from Dulloo
(1999).
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by Nagase et al. (1996) claiming that treatment with a b3
agonist led to weight loss associated with the expression
of a UCP detected in skeletal muscle and white adipose tis-
sue by Northern and Western probing for the BAT–UCP;
(2) the report of Rolfe & Brand (1996) that the phenomenon
of mitochondrial ‘proton leak’ is not unique to BAT as orig-
inally thought, but also exists in tissues other than BAT, and
could contribute as much as 50 % of the skeletal muscle heat
production at rest. Whatever the exact initial motivation(s)
behind this search for UCP in tissues other than BAT, it
led to the discoveries of two new members of the UCP
family (UCP2, UCP3) on the basis of their high sequence
homology to BAT–UCP, renamed UCP1 (Boss et al.
1997; Fleury et al. 1997; Gong et al. 1997; Vidal-Puig
et al. 1997). Unlike UCP1, which is expressed only in
BAT, UCP2 is expressed in all tissues so far examined
(including organs involved in immunity or rich in macro-
phages) while UCP3 is expressed predominantly in skeletal
muscles and BAT, and to a lesser extent in white adipose tis-
sue and in the heart (Table 1). These discoveries stimulated
the search for other UCP1 homologues, and resulted in the
cloning of brain mitochondria carrier protein 1 and UCP4,
which are both predominantly expressed in neural tissues,
notably the brain (Sanchis et al. 1998; Mao et al. 1999),
although transcripts of brain mitochondria carrier protein
1 (which has also been referred to as UCP5) have also
been reported in multiple human and mouse tissues, includ-
ing in white and brown adipose tissue, liver, skeletal muscle,
gut, kidney, heart, brain, testis (Yu et al. 2000). The family
of mitochondrial carrier proteins is still growing with the
identification of genes encoding UCP1 homologues in
birds, fish, and even in plants (e.g. potato), fungi and proto-
zoa (Pecqueur et al. 2001b).
‘Thermogenesis’ hypothesis
Considered as breakthrough discoveries, the cloning of
these UCP1 homologues has generated considerable enthu-
siasm for the hypothesis that, by analogy to UCP1 in BAT,
they may be mediators of thermogenesis in other tissues,
and UCP2 and UCP3 became the long-awaited candidate
genes controlling skeletal muscle heat production and
hence candidate genes that underlie adaptive thermogenesis
in weight regulation. Such ‘thermogenesis’ hypothesis
Fig. 3. Schematic diagram showing the response of the sympathetic nervous system (SNS)–(BAT)–uncoupling protein UCP axis to changes
in diet and environmental temperature. Adapted from Dulloo & Samec (2000). Max, maximum; min, minimum. Note that within their respective
thermoneutral zones, adult man ressembles the laboratory rat in that both species maintain the capacity for energy conservation during star-
vation via the suppression of thermogenesis, and that the capacity to exhibit diet-induced thermogenesis during overfeeding, which is rather
poor at thermoneutrality when the diet is well-balanced, is more apparent in response to low-protein diets (Dulloo & Jacquet, 1999; Stock,
1999a).
Table 1. Family of mitochondrial uncoupling proteins in mammals
Members
Amino acid identity to UCP1
(%) Tissue/organ distribution
UCP1 – Brown adipose tissue (BAT)
UCP2 55 Ubiquitous
UCP3 57 Skeletal muscle, BAT (white adipose tissue, heart)
BMCP1 34 Brain and neural tissues
UCP4* 29 Brain and neural tissues
* The low sequence identity to UCP1 suggests that it may be inappropriate to describe this protein as a UCP1
homologue.
UCP, uncoupling protein; BAT, brown adipose tissue; BMCP, brain mitochondria carrier protein.
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about the role of these UCP1 homologues received con-
siderable support from the following demonstrations:
(1) transfection or overexpression of these genes in yeast or
other cell culture systems yielded data which are con-
sistent with mitochondrial uncoupling properties (Ric-
quier & Bouillaud, 2000);
(2) the gene expressions of UCP2 and UCP3 in adipose tis-
sue or in skeletal muscle were found to be increased in
response to in vivo manipulations that are known to
stimulate thermogenesis, e.g. cold exposure, high-fat
feeding in obese-resistant rats and mice, administration
of thyroid hormones, treatment with adrenoceptor ago-
nists or during infusion with leptin (Gong et al. 1997;
Ricquier, 1999);
(3) in situ hybridization studies in brains of the mice and
non-human primates, revealed abundance and distri-
bution patterns of UCP2, brain mitochondria carrier
protein 1 and UCP4 which suggest that these UCP1
homologues could be part of neural circuitries involved
in neuroendocrine, autonomic and metabolic regu-
lations, and might contribute to the metabolic rate and
thermoregulation of the neural structures to which
they are associated (Mao et al. 1999; Richard et al.
1999; Sanchis et al. 1998; Diano et al. 2000);
(4) the modulation of murine brain mitochondria carrier
protein 1–UCP5 gene expression by conditions that
alter adaptive thermogenesis (fasting or cold) has also
been reported for the brain and liver (Yu et al. 2000),
with the mRNA levels in both these tissues being
increased following acute exposure to cold, and
reduced during fasting in the liver, though not in the
brain;
(5) furthermore, the expression of genes coding for other
UCP1 homologues in the skeletal muscles of chicken
(Raimbault et al. 2001) and hummingbirds (Vianna
et al. 2001), as well as in plants (Pecqueur et al.
2001b), is upregulated in response to cold, and hence
associated with the need for thermoregulatory thermo-
genesis or resistance against chilling.
Starvation paradox
A major challenge for the ‘thermogenesis’ hypothesis,
however, is how to reconcile the uncoupling properties of
UCP2 and UCP3 found during their overexpressions in
cell systems with the fact that their gene expressions in
the skeletal muscle are increased during starvation both
in human subjects (Millet et al. 1997) and in the laboratory
animals (Boss et al. 2000), a directional change in gene
expression that is opposite to that expected for any putative
mediator of adaptive thermogenesis in a well-established
condition of energy conservation. Proponents for this
hypothesis have argued that the upregulation of these
muscle UCP1 homologues during starvation may still be
reflecting an uncoupling effect, but whose functional
importance is to meet the increased thermoregulatory
needs of the body, consequential to starvation-induced
body wasting, loss of fat insulation, and energy conserva-
tion in other tissues. This explanation is, however, difficult
to accept in the light of evidence that: (1) during fasting
conducted at thermoneutrality, which minimises the thermo-
regulatory needs, the gene expressions of these muscle UCP
homologues remained markedly upregulated (Samec et al.
1998a); (2) in any event, direct measurements of regional
metabolic rate in various tissues or organs, have clearly
demonstrated that the skeletal muscle is a quantitatively
important site of energy conservation during starvation
(Ma & Foster, 1986).
Further dissociations
To gain insights into the putative role of skeletal muscle
UCP2 and UCP3 as mediators of thermogenesis in weight
regulation, several other studies in our laboratory were
designed to assess, in the rat, the changes in skeletal muscle
UCP2 and UCP3 gene expression in response to other diet-
ary manipulations that alter whole-body energy expenditure
and thermogenesis. In each study, measurements of UCP
mRNA levels were made from skeletal muscles of widely
different fibre-type composition, and removed from animals
which were sacrificed at time-points which, under con-
ditions of our studies, correspond to dynamic changes in
energy expenditure, thermogenesis, and body composition.
The results (Figs. 4 and 5) indicate that the correlations
between skeletal muscle UCP2 and UCP3 gene expression
and dietary regulation of thermogenesis are rather poor
since:
(1) during early days of refeeding (after fasting), the
mRNA levels of these muscle UCP1 homologues
were markedly downregulated, irrespective of whether
the refed animals were partially food restricted and
normophagic (an overall state of reduced thermo-
genesis) or were fed ad libitum and hyperphagic, an
overall state of enhanced thermogenesis due to
increased DIT (Samec et al. 1998a, 2000a);
(2) during refeeding at thermoneutrality (298C) or in the
cold (68C), the refed animals still showed reduced
thermogenesis relative to their respective controls, but
mRNA levels for UCP3 were reduced at thermoneutral-
ity but not in the cold (Samec et al. 2000b);
(3) isoenergetic substitution of carbohydrates for fat
resulted in higher mRNA levels of muscle UCP2 and
UCP3, but thermogenesis was lower on the high-fat
diet than on the low-fat diet (Samec et al. 1999);
(4) alterations in the fatty acid composition of diet in
favour of n-6 polyunsaturated fats or in medium-
chain triacylglycerols resulted in enhanced thermogen-
esis, but these had no impact on mRNA levels of these
muscle UCP1 homologues (Samec et al. 1999);
(5) similarly, neither skeletal muscle UCP2 nor UCP3
mRNA levels were altered when DIT was markedly
increased in response to a low-protein diet (Samec
et al. 2000a), a potent stimulator of thermogenesis
even under these experimental conditions (Dulloo &
Girardier, 1992).
Taken together, these studies suggest that changes in skel-
etal muscle UCP2 and UCP3 gene expressions can be disso-
ciated not only from suppressed thermogenesis during
fasting, but also from a variety of dietary stimuli that modu-
late thermogenesis during refeeding. The subsequent
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Fig. 5. Summary of data investigating the effect of dietary manipulations on skeletal muscle (UCP) 3 gene expression in the rat. See legend of
Fig. 4. HF, high fat; LF, low fat. Mean values were significantly different from respective controls: * P , 0:05:
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Fig. 4. Summary of data investigating the effect of dietary manipulations on skeletal muscle uncoupling protein (UCP) 3 gene expression in
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demonstration that during fasting, the skeletal muscle
showed a marked 4–5-fold increase in UCP2 and UCP3
mRNA levels and a 2-fold increase in UCP3 protein, but
without any difference in the kinetics of proton conductance
pathway in mitochondria from this tissue, further dissociates
skeletal muscle UCP2 and UCP3 regulation from changes in
proton leak (Cadenas et al. 1999). These conclusions have
recently been confirmed by Jucker et al. (2000) who, utilis-
ing a non-invasive NMR approach with isotopic labelling to
measure the degree of mitochondrial energy coupling in the
hindlimb muscles of awake rats, found that fasting-induced
increases in UCP3 mRNA and protein expression (by 2–
3-fold) occurred in the absence of any detectable change
in mitochondrial energy coupling. What then could be the
physiological significance of UCP2 and UCP3 gene upregu-
lation in the skeletal muscle during starvation ?
Uncoupling proteins or substrate carriers?
The re-evaluation of our data on UCP1, UCP2 and UCP3
with the state of knowledge about skeletal muscle and
BAT metabolism during starvation (Samec et al. 1998a)
revealed that the only common association in both tissues
was in parallel changes in their expressions and the utiliz-
ation of lipids as fuel substrate (Fig. 6). In BAT, the
decreases in gene expressions of UCP2 and UCP3 are in
parallel to the decrease in utilization of lipids as metabolic
fuel due to a general downregulation of metabolic activity
in this tissue, consequential to the suppressive effect of fast-
ing on the SNS–BAT–UCP1 axis. In the skeletal muscle,
the increased UCP2 and UCP3 expression is in line with
the well-known fasting-induced shift in substrate utilization
in favour of lipids as the predominant metabolic fuel, and
hence allowing the sparing of glucose for organs and/or tis-
sues with an obligatory requirement for glucose, notably the
brain. Could it then be that the structural homology of UCP2
and UCP3 to UCP1 has been made with the wrong function
of UCP1, since the primary function of this UCP as a
mediator of adaptive thermogenesis via mitochondrial pro-
ton leak has often been linked (by mechanisms that are
poorly understood) to a putative secondary function as an
anion and/or substrate transporter across the mitochondrial
membranes (Nedergaard & Cannon, 1992; Garlid et al.
1996; Jezek et al. 1998). After all, the gene sequences of
these muscle UCP1 homologues, like UCP1, all possess
mitochondrial carrier domains, which have served to clas-
sify them as members of the mitochondrial carrier protein
family. Like the UCP1 homologues, several of these sub-
strate carriers (e.g. adenine nucleotide and glutamate–
aspartate transporters) are also known to be able to catalyse
a fatty acid-dependent proton leak (hence possess uncou-
pling properties), although the physiological importance of
these pathways is also unclear (Brand et al. 1999). The re-
evaluation presented in Fig. 6 constituted the backbone of
our proposal that the primary function of UCP2 and UCP3
in the skeletal muscle and BAT may somehow be involved
actively or passively with the regulation of lipids as fuel
substrate rather than in the mediation of thermogenesis
(Samec et al. 1998a). The generality of the term ‘lipids as
fuel substrate’ was deliberate because of the multitude of
control points that could theoretically be invoked in the
handling of lipids in response to alterations in the flux of
lipid substrates. In particular, it was not known (and still
not clear) whether they are required at control points
along the fatty acid b-oxidation pathway or whether they
are involved in the prevention of lipotoxicity that may
arise from enhanced fatty acid oxidation or lipid storage.
The question was subsequently raised as to whether UCP2
and UCP3 should be considered as candidate genes for ther-
mogenesis or for ‘lipid handling’ (Dulloo, 1999).
‘Lipid handling’ hypothesis
In the construction of this alternative hypothesis about a role
for UCP2 and UCP3 in lipid handling (Fig. 6), supporting
evidence was also derived by re-interpreting data showing
increased gene expression of these UCP1 homologues in
skeletal muscle and/or in white adipose tissue in response
to cold and high-fat feeding or to the administration of thyr-
oid hormones, adrenergic agonists and leptin (Gong et al.
1997; Ricquier, 1999) since each of these stimuli stimulates
not only thermogenesis, but also enhances the utilization of
lipids as fuel substrate. At the same time, reports that new-
born mice do not express UCP3 in skeletal muscle until
suckling occurs, i.e. until ingestion of a fat-rich meal
(Brun et al. 1999), and that such upregulation of UCP3
gene expression can be induced in fasted newborn mice
given intralipid but not glucose, strengthened the link
between the circulatory supply of free fatty acids (FFA) as
fuel substrate, induction of UCP3 in skeletal muscle, and
an increase in utilisation of lipids of fuel substrate. Several
other lines of evidence, from studies in the skeletal muscle
and the heart, are consistent with this alternative hypothesis
for a physiological role of the UCP2 and UCP3 in lipid
handling:
First, upon transition from starvation to refeeding, the
gene expressions of these muscle UCP1 homologues were
found to be altered from a state of upregulation to one of
Fig. 6. Changes in brown adipose tissue (BAT) and skeletal muscle
thermogenesis, fuel substrate and gene expression of uncoupling
protein (UCP) 1, UCP2 and UCP3 in response to starvation. BAT,
brown adipose tissue; 0, no change; #, decrease; ", increase; "",
more pronounced increase. SNS, sympathetic nervous system.
Adapted from Dulloo & Samec (2000).
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downregulation below control levels (Samec et al. 1998a).
These findings could be interpreted as being consistent
with a role for these UCP1 homologues in the switching
of muscle substrate metabolism from a state of enhanced
lipid utilization during starvation (when glucose is limiting)
to one of reduced fat utilization during refeeding on a low-
fat diet when lipids need to be ‘spared’ for deposition during
a phase of increased metabolic efficiency and accelerated
replenishment of the fat stores (Dulloo & Girardier, 1990;
Dulloo & Jacquet, 2001). Since it costs less energy to
store fat from dietary lipids than to synthesize fat from
carbohydrates (via de novo lipogenesis), a shift in muscle
substrate utilization in favour of glucose during intake of
a low-fat–high-carbohydrate diet would be an energetically
more efficient way for depositing fat, and would be in keep-
ing with a role for these muscle UCP1 homologues in lipid
handling.
Second, support for the latter contention linking downre-
gulation of muscle UCP1 homologues and lipid sparing can
be derived from the findings (Samec et al. 1999) that the
downregulation of muscle expression of UCP2 and UCP3
during refeeding on a low-fat diet is prevented by high-fat
refeeding, i.e. when the availability of dietary lipids (for
rapid fat replenishment) is no longer a limiting factor and
the need for de novo lipogenesis is obviated.
Third, the observation that the changes in UCP2 and
UCP3 expressions during starvation and refeeding are
more pronounced in ‘white’ muscles (predominantly fast
glycolytic) than in ‘red’ muscles (predominantly slow oxi-
dative) (Samec et al. 1998a) are consistent with the greater
dependency of slow oxidative muscles on lipids as fuel sub-
strate, and the greater shift between glucose and lipids as
fuel substrate in fast glycolytic muscles during fasting and
refeeding. In fact, the more pronounced fasting-induced
upregulation of UCP2 and UCP3 gene expression in the
fast twitch glycolytic muscles occur in parallel to a more
pronounced upregulation of key regulators of lipid oxi-
dation (carnitine palmitoyltransferase I, medium-chain
acyl-CoA dehydrogenase, long-chain acyl-CoA dehydro-
genase) in the fast glycolytic than in the slow oxidative
muscles of the rat (Hildebrandt & Neufer, 2000; Samec
et al. 2001).
Fourth, the recent findings of Schrauwen et al. (2001) that
high-fat induced upregulation of skeletal muscle UCP2 and
UCP3 gene expressions is more pronounced in human sub-
jects with a high proportion of type IIA fibres (which have a
higher capacity to shift from glucose to lipid oxidation than
type I muscle fibres) are in line with muscle-type differences
in the dietary regulation of UCP1 homologues, and coherent
with their role in lipid utilization.
Fifth, there is also evidence for a link between UCP2 or
UCP3 and the utilisation of lipids as fuel substrate in the car-
diac muscle.The expression of UCP2, which is low in the
fetal heart, increases rapidly after birth in parallel to the con-
tribution of lipids to cardiac fuel metabolism (Van der Lee
et al. 2000). In the adult rat, unpublished results indicate
that UCP3 gene expression is also increased in the heart
during fasting, and in parallel to those for long chain acyl-
CoA dehydrogenase and carnitine palmitoyl transferase I,
two key enzymes implicated in lipid oxidation (KAJM
Van der Lee, unpublished results).
Finally, the association in human subjects between poly-
morphism in UCP3 and in UCP2 with significant reductions
in basal and 24 h lipid oxidation respectively (Argyropoulos
et al. 1998; Astrup et al. 1999), is also consistent with the
proposal of a physiological role for these UCP1 homologues
in the regulation of lipids as fuel substrate.
Adipose-derived signals
Since the increases and decreases in skeletal muscle UCP2
and UCP3 gene expressions during starvation and refeeding
respectively, occur in parallel to the changes in the release
of FFA from the adipose tissue into the circulation, the
hypothesis was also tested that these changes in circulating
FFA, in addition to providing fuel substrate, may also have a
role as an inter-organ signal linking the dynamic changes in
adipose tissue fat stores to skeletal muscle UCP2 and UCP3
gene regulation. By utilizing the anti-lipolytic agent nic-
otinic acid to reduce the flux of FFA from the adipose tissue
into the circulation, we were able to show that abolishing the
surge in circulating FFA during fasting completely prevents
the upregulation of UCP2 and UCP3 in a slow oxidative
(soleus ) muscle but not in fast glycolytic (gastrocnemius )
nor fast oxidative–glycolytic (tibialis anterior ) muscles
(Samec et al. 1998b). Similar heterogeneity in muscle
UCP2 and UCP3 responses to nicotinic acid was also
observed in fed animals, in which the reduction in circulat-
ing FFA (to levels comparable with that observed during
early refeeding) resulted in reduced gene expression of
both muscle UCP1 homologues in the slow oxidative
muscle, but not in fast glycolytic nor fast oxidative-glyco-
lytic muscles (Samec et al. 1998b).
Taken together, these results suggest that the hypothesis
that circulating FFA functions as a physiological inter-
organ signal between adipose tissue fat stores and skeletal
muscle UCP1 homologues is adequate only for the slow
oxidative muscle but not for the fast-twitch muscles. Con-
sequently, a signal(s) other than circulating FFA may be
implicated in the link between the dynamic changes in adi-
pose tissue fat stores and UCP gene expression in the pre-
dominantly fast twitch muscles, which constitute the major
muscle-type of the total skeletal muscle mass in rodents
and in man. On the basis of studies showing that the
gene expression of UCP1 homologues in skeletal muscles
are switched from a state of upregulation during starvation
to one of downregulation (below control levels) during
refeeding, such a candidate signal(s) or modulator(s)
must operate in a way that would be compatible with a
‘switch’ in the pattern of expression of these UCP1 homo-
logues in response to such dietary manipulations. Presum-
ably, this would exclude known endocrine adaptations to
starvation, a contention that would be in line with reports
that neither leptin (Weigle et al. 1998), glucocorticoids
(Weigle et al. 1998) nor insulin (Millet et al. 1997)
could be implicated in fasting-induced upregulation of
muscle gene expression of UCP2 and UCP3.
To what extent the newly characterized signaling mol-
ecule resistin, which is expressed specifically in adipose
tissue and is released into the circulation to induce insulin
resistance (Steppan et al. 2001), may function as this postu-
lated adipose-derived hormone that regulates UCP2 and
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UCP3 expression in glycolytic muscle, would be an interest-
ing line for future investigations. This is particularly so
because of evidence indicating that in response to high-fat
feeding, the gene expressions of UCP2 and UCP3 in the pre-
dominantly fast glycolytic muscle are positively correlated
with glucose intolerance and hence possibly with insulin
resistance (Samec et al. 1999). Whatever the adipose-
derived signal, however, the more recent findings (Samec
et al. 2001) of a much more pronounced fasting-induced
upregulation of genes encoding UCP2 and UCP3 as well
as key regulators of lipid oxidation, carnitine palmitoyl-
transferase I and medium-chain acyl-CoA dehydrogenase
in the glycolytic than in the slow oxidative muscles (even
when the surge in plasma FFA is abolished by nicotinic
acid) raise the possibility that these UCP1 homologues are
likely to be involved with the regulation of lipids as fuel
substrate under conditions when glycolytic muscles are
‘forced’ to shift substrate from glucose to lipids rather
than in a more ‘basal’ utilization of lipids as fuel substrate.
Biochemical models for ‘lipid handling’
Whether this postulated physiological role of UCP2 and
UCP3 in lipid handling can be attributed to the control of
lipid oxidation or to the prevention of lipotoxicity is not
clear. According to some authors (Boss et al. 2000) a role
for UCP3 as a transporter of fatty acid into the mitochon-
drial matrix (where fatty acid oxidation occurs) is unlikely
since: (1) the matrix lacks fatty acyl-CoA transferase
activity and fatty acyl-CoA; (2) the substrate for b-oxidation
has been shown not to be transported by UCP1. They also
point out that UCP3 cannot mediate fatty acid transport as
it relates to b-oxidation on the grounds that fatty acid–car-
nitine carriers which transport fatty acids into the matrix has
a low similarity (20 % identity) with UCP1, UCP2 or UCP3.
However, one wonders about the validity of rejecting carrier
function solely on the basis of amino-acid identity to the
carnitine carrier.
A number of biochemical models have in fact been pro-
posed in which these UCP1 homologues would operate as
fatty-acid carriers across the mitochondria, and the function
of UCP2 and/or UCP3 would be to export fatty acids out of
the mitochondria when fatty acid oxidation predominates,
such as in the skeletal muscle during fasting and high-fat
feeding (Simoneau et al. 1998; Weigle et al. 1998; Schrau-
wen et al. 2001; Himms-Hagen & Harper, 2001). In most of
these models, UCP2 and/or UCP3 are postulated to be
involved in the translocation of the fatty acid anions from
the matrix side to the cytosolic side of the mitochondrial
membrane. The fatty acid anions would be protonated and
the UCP1 homologues would then ‘flip–flop’ these neutral
fatty acids back to the matrix side (Garlid et al. 1996),
resulting in a lowering of the proton gradient and hence
increased heat production. Within these models of fatty
acid cycling therefore, the UCP1 homologues would exert
an uncoupling effect by being involved in translocating an
excessive amount of fatty acid anions out of the
mitochondrion.
In the model proposed by Himms-Hagen & Harper
(2001), by contrast, UCP3 is also postulated to function as
a transporter protein, but the energy cost for the operation
of this cycle would be due mainly to the ATPase effect
rather than uncoupling via proton entry. According to
their model, excess acyl-CoA within the mitochondria is
hydrolysed by a mitochondrial acyl-CoA thioesterase,
yielding fatty acid anion and free CoA (CoASH). The
fatty acid anion is exported to the cytosol by being carried
across the inner mitochondrial membrane by UCP3. The
postulated function of the fatty acid export cycle would be
to liberate CoASH for other uses at times of dependence
on fatty acid oxidation as an energy source, i.e. in order
for CoASH to participate in other reactions for which it is
needed during fatty acid oxidation in the b-oxidation
cycle and in the tricarboxylic-acid cycle. The export of
fatty acid anion thus permits continued rapid fatty acid oxi-
dation in the face of an oversupply, while at the same time
eliminating from the mitochondrion a potentially deleter-
ious substance, FFA, that it is unable to metabolize. The var-
ious components of all these models remain speculatory and
convincing evidence that a potential source of fatty acid
anions in the mitochondrial matrix derives from the
hydrolysis of acyl-CoA by an acyl-CoA thioesterase is yet
to be reported.
Interpreting outcome of genetically-modified systems
The use of gene knockout (KO) technology to elucidate the
role of UCP1 and UCP1 homologues in energy balance and
substrate metabolism have, in general, been disappointing,
since mice lacking UCP1, UCP2, UCP3, or both UCP1
and UCP3 do not become obese and have a phenotype simi-
lar to control mice: they do not appear to show major
impairments in whole-body resting metabolic rate, DIT,
total energy expenditure nor in substrate metabolism (Ener-
ba¨ck et al.1997; Arsenijevic et al. 2000; Kozak & Harper,
2000; Gong et al. 2000; Vidal-Puig et al. 2000; Harper &
Himms-Hagen, 2001). There are, however, many pitfalls
in interpreting results from these gene KO and transgenic
experiments. As recently emphasized by Williams &
Wagner (2000), unexpected consequences of genomic
modifications are frequent, and the phenotype or lack of
phenotype observed in any transgenic experiment is a func-
tion of both the planned genetic modification and of second-
ary responses of the organism to that perturbation. A
dramatic example of this principle was demonstrated in
the case of myoglobin KO mice, which either die in utero
or survive by adaptive responses that compensate for the
absence of myoglobin by steepening the PO2 gradient and
reducing the diffusion path length for O2 between capillaries
and the mitochondria (Williams & Wagner, 2000). Thus,
since the knocking out of genes for reasonably well estab-
lished functions often fail to reveal the expected impairment
in these functions because of compensatory mechanisms
(known or unknown), the failure of UCP-KO mice to reveal
major impairments in weight regulation via thermogenesis
or substrate metabolism is not sufficient to reject the hypoth-
esis that these UCP1 homologues play a role in thermogen-
esis or lipid metabolism.
Indeed, despite the fact that no differences in energy
expenditure nor in respiratory quotient could be found at
the whole-body level, mice lacking UCP3 show several bio-
chemical impairments in skeletal muscle metabolism,
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namely: (1) increased efficiency of ATP production, as
assessed by in vivo studies using nuclear magnetic
resonance with isotopic labelling (Cline et al. 2001); (2)
reduced in vitro mitochondrial proton leak and increased
reactive oxygen species (ROS) production (Gong et al.
2000; Vidal-Puig et al. 2000); and (3) a tendency for
impaired starvation-induced shift in lipid partitioning
between oxidation and storage (Muoio et al. 2000). Conse-
quently, these impairments in muscle metabolism must have
been compensated by other mechanisms.
An even stronger argument can be made in the case of
UCP1, since the failure to show changes in body fat stores
in UCP1-KO mice can be weighed against ample pharmaco-
logical and surgical evidence that implicate UCP1 in DIT
and in weight regulation (Kozak & Harper, 2000; Harper
& Himms-Hagen, 2001). In the UCP1-KO mice, the marked
elevation of UCP2 mRNA and no change in UCP3 mRNA
levels in their BAT do not substitute for UCP1 in adrenergi-
cally or fatty acid-induced BAT thermogenesis (Matthias
et al. 2000), but recent studies indicate that the mitochon-
drial proton leak in skeletal muscle mitochondria is
increased, albeit without any change in UCP2 and UCP3
gene expression (Monemdjou et al. 2000). Such findings
underline the importance and complexity of compensatory
thermogenic mechanisms that allows mice lacking UCP1
to stay lean at room temperature, and underscore the diffi-
culties of interpreting physiological importance (or lack of
it) by gene KO technology.
Uncoupling during uncoupling-protein overexpression:
biological or artifactual?
Similarly, the report that transgenic mice overexpressing
human UCP3 in skeletal muscle show markedly elevated
metabolic rates, lipid oxidation and increased proton leak
(Clapham et al. 2000) neither establishes the normal physio-
logical role of this UCP homologue, nor does it tell us which
is the primary effect of UCP3 overexpression: is it an
increase in heat production that could have resulted from
an exaggerated increase in UCP3-mediated proton leak,
which then drives lipid use or flux, or is it primarily due
to a massive increase in UCP3-mediated fatty acid flux
across the mitochondria with resulting ‘uncoupling effects’
of fatty acids and/or increased proton leak that is secondary
to carrier-mediated fatty acid transport. Furthermore, one
cannot disregard the possibility that the huge (.60-fold)
increase in UCP3 mRNA levels observed in muscles from
these transgenic mice has the potential to result in extra pro-
tein synthesis to an extent that could lead to alterations in
the mitochondrial membrane integrity and which hence
might account for the increase in proton leak. In this con-
text, evidence emerging from the laboratory of Brand and
co-workers (Stuart et al. 2001a) raise serious concerns
about the facile attribution of ‘uncoupling’ properties to
UCP homologues in genetically-manipulated model sys-
tems. In a recent study assessing the ability of human
UCP2 to uncouple mitochondrial oxidative phosphorylation
when expressed in yeast at physiological and supraphysio-
logical levels (Stuart et al. 2001b), they came to the
conclusions that; (1) proton conductance increased only
with supraphysiological doses, resulting in an inhibition of
substrate oxidation which cannot be readily explained by
an uncoupling activity of UCP2; (2) quantitatively, even
the uncoupling seen at such high doses was insufficient to
account for the basal proton conductance of mammalian
mitochondria. Furthermore, the uncoupling caused by high
expression of UCP2 was quantitatively almost the same as
the artifactual uncoupling caused by the same quantity of
UCP1. These observations suggest that uncoupling of
yeast mitochondria by UCP2 is an overexpression artifact
leading to compromised mitochondrial integrity. This may
also apply to other UCP homologues and in other geneti-
cally-modified systems: to quote Stuart et al. (2001a ):
‘The existence of artifactual uncoupling under some con-
ditions of UCP expression, and the inhibition of substrate
oxidation that can accompany it, both suggest that the gen-
etic manipulation of protein expression can affect the mito-
chondrion in secondary ways that manifest as the very
phenotypes hypothesised for the UCP1 homologues’.
‘Mild uncoupling’ hypothesis
Nonetheless, if UCP2 and UCP3 were to possess true uncou-
pling properties under physiological conditions, these may
be of only marginal quantitative significance vis-a`-vis heat
production, given the poor association of their gene
expressions with altered thermogenesis in general, and the
lack of detectable fasting-induced alterations in the effi-
ciency of mitochondrial coupling in skeletal muscle in
vitro or in vivo despite marked upregulation of UCP2
mRNA, UCP3 mRNA, and/or UCP3 protein (Cadenas
et al. 1999; Cline et al. 2001). According to earlier work
of Skulachev (1996), it was proposed that the mitochondria
do in fact possess a mechanism called ‘mild’ uncoupling,
which prevents large increases in the proton electrochemical
gradient when ADP is not available (during stage four res-
piration), and that this mechanism reduces the production
of ROS by the respiratory chain, and modulate the
ATP:ADP ratio. In most cells, the majority of ROS, H2O2
and superoxide anion, is generated by the mitochondrial
electron transport respiratory chain (Skulachev, 1998), and
if they overwhelm the oxidant defence of the cell, they
can result in damage to cellular macromolecules such as
lipids, protein and DNA, i.e. a state of oxidative stress. Con-
sequently, it could be argued that even if the uncoupling
capacity of a given UCP1 homologue is weak and difficult
to detect under physiological conditions, it can have an
important role in the mediation of the ‘mild’ uncoupling
mechanism and hence in the control of ROS within the
cell. Evidence supporting such a role for UCP3 can be
derived from studies revealing that mitochondria isolated
from skeletal muscle of mice lacking UCP3 showed a ten-
dency for reduced proton leak and increased ROS pro-
duction (Vidal-Puig et al. 2000).
A role for UCP2 in limiting ROS production and in the
prevention of excess oxidative damage was in fact proposed
by Ne´gre-Salvayre et al. (1997) soon after the cloning of
this UCP1 homologue. Using mitochondria isolated from
spleen, thymus and nonparenchymal liver cells (all of
which express UCP2 abundantly), they showed that GDP,
an inhibitor of UCP1, increased both mitochondrial mem-
brane potential and H2O2 generation. It is however not
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clear whether these effects of GDP in increasing ROS pro-
duction was due to inhibition of UCP2 activity or to some
other mechanisms, but GDP was also found to increase
both mitochondrial membrane potential and H2O2 gener-
ation in mitochondria isolated from BAT (which expresses
UCP1, UCP2 and UCP3), but not from hepatocytes deprived
of UCP2. They proposed that all UCP homologues (includ-
ing UCP1) could be proteins that participate in the control of
mitochondrial ROS production, and therefore in the control
of the the redox state and oxidative stress of the cell. In sup-
port of these proposals is the more recent demonstration of
Arsenijevic et al. (2000) that macrophages from mice with
disruption in the UCP2 gene generated more ROS and had
greater toxoplasmacidal activity in vitro than wild-type
mice, which could explain their resistance to parasitic infec-
tion with Toxoplasma gondii.
‘Lipid-related reactive oxygen species’ hypothesis
A role for UCP2 in lipid-related oxidative stress of the cell is
also supported by the demonstrations that excess lipid oxi-
dation and/or excess lipid storage lead to the production
of ROS (Berson et al. 1998; Pastore et al. 2000) and that
UCP2 is overexpressed under both conditions of enhanced
lipid oxidation (e.g. in muscle and heart during fasting) as
well as in cells or tissues in which lipid accumulates, nota-
bly:
(1) in white adipose tissue of genetically obese animals or
mice made obese by high-fat feeding (Kozak & Harper,
2000);
(2) in brown adipocyte of mice deficient in UCP1 and of
transgenic mice overexpressing glycerol 3-phosphate
dehydrogenase (Kozak & Harper, 2000);
(3) in the hepatocytes of two mouse models of fatty liver:
the genetically obese ob/ob mouse and ethanol-fed
lean mouse (Rashid et al. 1999);
(4) in skeletal muscle of obese subjects (Simoneau et al.
1998) or in tetraplegic patients (Hjeltnes et al. 1999),
i.e. under conditions of elevated intramuscular lipids.
In tissues accumulating lipids and in which UCP2 and UCP3
co-exists, UCP2 gene overexpression tends to be more pro-
nounced. This specificity of UCP2 overexpression in the
response to elevated lipid storage is underscored by the find-
ings that lipid accumulation in BAT of UCP1-KO mice is
associated with very marked (5–15-fold) increases in
UCP2 mRNA levels and this contrast with no increase or
even mild reduction in UCP3 mRNA levels (Enerba¨ck
et al. 1997; Matthias et al. 2000; Harper & Himms-
Hagen, 2001). Consequently, while UCP3 can be postulated
to operate primarily at control points along pathways
directly linked to lipids as fuel substrate and to fatty acid
b-oxidation, UCP2 could be acting primarily at control
points in the prevention of lipotoxity and/or oxidative
damage (through ROS control) consequential to both excess
fatty acid oxidation and lipid accumulation. The induction
of UCP2 expression may thus be a crucial adaptive response
to prevent the toxic effects of excessive lipid storage and/or
lipid metabolism in the cell. In fact, evidence that ROS
generated intracellularly during lipid metabolism partici-
pates in UCP2 induction can be derived from the findings
that cultures of rat hepatocytes treated with lipid emulsion,
linoleic or oleic acid resulted in increased UCP2 gene and
protein expressions, which were not altered by the addition
of cell-impermeable antioxidant glutathione (Cortez-Pinto
et al. 1999). The mechanisms by which lipid oxidation
and/or lipid accumulation induce UCP2 expression and
ROS production and their roles in the prevention of lipotox-
icity are certainly avenues for further investigations towards
elucidating the role of UCP1 homologues in lipid handling.
Conclusions and perspectives
This review has concentrated on the analysis of potential
functional roles for UCP1 and its homologues UCP2 and
UCP3 in the mediation of thermogenesis and substrate
metabolism. Given the present state of knowledge, it can
be concluded that there is no good evidence that UCP1
homologues mediate thermogenesis. In contrast, there are
strong associations between these UCP1 homologues and
the regulation of lipids as fuel substrate in skeletal muscle,
and strong links between UCP2 (and to a lesser extent
UCP3) and the control of ROS production in a variety of
tissues or organs. There are also several indications, in par-
ticular the differential responses of UCP2 and UCP3 gene
expression to the increase in lipid storage in BAT from
UCP1-KO mice, that UCP2 overexpression is more closely
related to lipid-related oxidative stress, whereas UCP3 is
more tightly correlated with lipid oxidation.
A conceptual model
On the basis of these observations, it is postulated that
UCP2 and UCP3 have distinct primary functions, with a
role for UCP3 in regulating the flux of lipid substrates across
the mitochondria, and that for UCP2 in the control of mito-
chondrial generation of ROS. The distinct functions of these
UCP1 homologues have been incorporated in a conceptual
model diagram (Fig. 7) which illustrates how in a given tis-
sue or organ, UCP2 and UCP3 may act in concert in the
overall regulation of lipid oxidation concomitant to the pre-
vention of lipid-induced oxidative damage; for example in
BAT in response to cold or in skeletal muscle in response
to starvation, two situations when the gene expression of
both UCP2 and UCP3 are upregulated (Samec et al.
1998a; Denjean et al. 1999; Himms-Hagen & Harper,
2001). Indeed, during cold-induced thermogenesis in
BAT, lipid oxidation is markedly increased when UCP1 is
activated to catalyse the proton leak and uncouple mito-
chondrial respiration for the purpose of thermoregulatory
thermogenesis. The distinct roles of UCP3 in controlling
the elevated flux of lipid substrates and that of UCP2 in con-
trolling excessive ROS production in response to this
increased flux of lipid substrates can thus be viewed as
complementary to the function of UCP1 in activating ther-
mogenesis and lipid oxidation and to the consequences of
this function. Similarly, during fasting-induced suppression
of thermogenesis in skeletal muscle for the purpose of
energy conservation, when the fuel substrate shifts to lipids
and lipid oxidation increases, the role of UCP3 in control-
ling the flux of lipid substrates is also co-ordinated with
the role of UCP2 in buffering the impact of such high
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level of lipid oxidation on the production of ROS and hence
in the prevention of lipid-induced oxidative damage.
Whether the mechanisms by which these two UCP1 homo-
logues exert their distinct primary functions involve altera-
tions in proton leak via the phenomenon of ‘mild’
uncoupling is uncertain, but this is certainly an attractive
hypothesis. Given the almost ubiquitous tissue expression
of UCP2, an important feature of this model is that it also
allows a role for UCP2 in the control of ROS production
and in oxidative stress in response to stimuli other than
those linked to alterations in lipid metabolism.
From genes to bioactive proteins
These postulations about the functional roles of UCP2 and
UCP3 must, however, be treated with caution since the
bulk of these associations between UCP2 or UCP3 with
lipid metabolism (or dissociations with thermogenesis)
have been made with the UCP1 homologues assayed at
the transcriptional (mRNA) level. Since translational regu-
lation can occur, as recently demonstrated for UCP2 by Pec-
queur et al. (2001a ), it is possible that their mRNA levels do
not always reflect the expression of the protein itself.
Equally valid, however, is the possibility that the protein
levels do not always reflect the biological activity of the pro-
tein in vivo. This issue was raised by Stock (1999b ) while
referring to the problems encountered when extrapolating
from studies at the molecular level to what happens in the
whole animal. He drew attention to the fact that: ‘manipula-
tions resulting in an increase in UCP1 gene expression
(mRNA), or even in mitochondrial UCP1 protein content,
do not necessarily result in an increase in thermogenesis’
(Stock, 1999b). He went on to illustrate his point with the
well-known example of the cold-adapted rat which, when
brought into a warm laboratory, will retain a high mitochon-
drial concentration of UCP1 for several days (Peachey et al.
1988) even though it is not exhibiting any non-shivering
thermogenesis. This is because BAT activation by the
SNS switches off as soon as the cold stimulus is removed.
With the current limitations of gene KO technology and
other genetically-modified systems for evaluating or inter-
preting the functional role of a given mitochondrial protein,
the transition from ‘associative’ to ‘causal’ evidence for the
physiological roles of UCP1 homologues will have to await
the development of assays that are sensitive to changes in
the activity of these proteins. However, with emerging evi-
dence also suggesting that the UCP1 homologues are unli-
kely to be responsible for the observed basal level of
uncoupling observed in mitochondria (Stuart et al. 2001a),
and that to date no physiological changes known to alter
adaptive thermogenesis (e.g. starvation, overfeeding) have
been shown to result in changes in basal proton conduc-
tance, a fundamental issue that needs to be addressed is
whether the UCP1 homologues or any other mitochondrial
membrane protein may provide an inducible pathway
through which proton conductance can be altered in mito-
chondria, as UCP1 does in BAT.
Uncoupling protein 1 homologues and food intake
In the meantime, the available evidence cast serious doubts
about the role of UCP2 and UCP3 in the mediation of adap-
tive thermogenesis, but at the same time open new perspec-
tives for these UCP1 homologues in metabolic regulation:
that of candidate genes for the regulation of substrate metab-
olism, particularly in the skeletal muscle. Given evidence of
the past decade linking the regulation of substrate balance
(particularly between the intake and oxidation of fats and
carbohydrates) to energy balance regulation via changes
in appetite, these UCP1 homologues via their postulated
role in regulating lipids as metabolic fuel may still play a
role in body-weight regulation via the control of food
intake. Furthermore, with the occurrence of three UCP1
Fig. 7. Conceptual model diagram embodying the postulation that
uncoupling protein (UCP) 2 and UCP3 have distinct primary func-
tions, with UCP3 implicated in regulating the flux of lipid substrates
across the mitochondria and UCP2 in the control of mitochondrial
generation of reactive oxygen species (ROS). The diagram illus-
trates how in a given tissue or organ, UCP2 and UCP3 may act in
concert in the overall regulation of lipid oxidation concomitant to the
prevention of lipid-induced oxidative damage; for example in brown
adipose tissue in response to cold or in skeletal muscle in response
to starvation, two situations when the gene expression of both
UCP2 and UCP3 are upregulated. During cold-induced thermogen-
esis in brown adipose tissue, lipid oxidation is markedly increased
when UCP1 is activated to catalyse the proton leak and uncouple
mitochondrial respiration for the purpose of thermoregulatory ther-
mogenesis. The distinct roles of UCP3 in controlling the elevated
flux of lipid substrates and that of UCP2 in controlling excessive
ROS production in response to this increased flux of lipid substrates
can thus be viewed as complementary to the function of UCP1 in
activating thermogenesis and lipid oxidation and to the conse-
quences of this function. Similarly, during fasting-induced suppres-
sion of thermogenesis in skeletal muscle for the purpose of energy
conservation, when the fuel substrate shifts to lipids and lipid oxi-
dation increases, the role of UCP3 in controlling the flux of lipid sub-
strates is also co-ordinated with the role of UCP2 in buffering the
impact of such high level of lipid oxidation on the production of
ROS and hence in the prevention of lipid-induced oxidative
damage. The broken lines (– – –) and the symbol (?) above them
underscore the possibility, but also uncertainty respectively, that the
mechanisms by which the two UCP1 homologues exert their distinct
primary functions involve alterations in proton leak via the phenom-
enon of ‘mild’ uncoupling. Given the almost ubiquitous tissue
expression of UCP2, an important feature of this model is that it
also allows a role for UCP2 in the control of ROS production and in
oxidative stress in response to stimuli other than those linked to
alterations in lipid metabolism. The putative role of UCP2 in oxi-
dative stress and modulation of ROS (and ATP:ADP ratio) may
also be extended to brain mitochondria carrier protein (BMCP) 1
and UCP4.
UCP4 BMCP1
?
?
Thermogenesis
Lipid substrate
Oxidative
stress
Proton leak
UCP1
UCP2
UCP3
ROS production
 (ADP : ATP)
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homologues (UCP2, brain mitochondria carrier protein 1
and UCP4) in the brain, together with further forthcoming
evidence that links the abundance of their expressions in
specific areas of the brain implicated with appetite control
(D Richard, unpublished results), the possibility arises that
one or more of UCP1 homologues could also turn out to
be gene(s) of importance in weight regulation, albeit as cen-
tral controller(s) of food intake rather than as peripheral
mediators of thermogenesis.
Refuelling an ancient metabolism
Paradoxically, the current difficulties in attributing a physio-
logical role to the UCP1 homologues in adaptive thermo-
genesis is occurring at a time when the biological
significance of DIT is being re-assessed. As outlined in
the legend to Fig. 3, man (like rats) seems to possess a
much larger capacity for DIT than is generally recognized,
but that capacity is poorly recruited on well-balanced
diets, but much more pronounced on diets low in essential
nutrients. As Stock (1999a ) has recently argued, the neces-
sity to increase DIT in the face of nutrient-deficient diets
probably had evolutionary survival advantage since it
enables overeating (on an energy basis) of such nutrient-
deficient diets in an attempt to achieve an adequate intake
of the specific nutrient without an excessive weight gain,
which would be a hindrance to optimal locomotion, hunting
capabilities and the ability to fight or flight. He went on to
propose that DIT may have evolved as a mechanism for reg-
ulating the metabolic supply of essential nutrients (protein,
minerals, vitamins) with only a secondary role in regulating
energy balance and body weight. Indeed, our own re-anal-
ysis of the classic human overfeeding studies of the 1960s
(Fig. 8) revealed that relatively small individual differences
in DIT on a balanced normal-protein diet are amplified on
protein-deficient diets (Dulloo & Jacquet, 1999). Conse-
quently, overfeeding on low-protein diets could provide a
very sensitive method for discriminating between those
who are metabolically predisposed to leanness or fatness.
Given the potent effect of protein deficiency on thermogen-
esis via the SNS–BAT–UCP1 axis in the laboratory rats or
mice even at thermoneutrality (Fig. 3), it remains to be seen
whether the use of such low-protein diets as a tool to
unmask some of the genetic and metabolic basis underlying
human susceptibility to obesity will pinpoint BAT and its
uncoupling protein (UCP1) or other yet to be discovered
mitochondrial protein as a source of human variability in
thermogenesis. In other words, it may prove necessary to
simulate the appropriate (unbalanced) dietary conditions
under which DIT is recruited in order to understand the mol-
ecular mechanisms by which the fire of life burns brighter in
some than in others.
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